China / 5 Top Trends in Healthcare & Biopharma in 2020
2020 has been eventful – perhaps the understatement of the year – but despite the novel coronavirus being…
2020 has been eventful – perhaps the understatement of the year – but despite the novel coronavirus being…
The latest pharma news from the Asia-Pacific region, including upcoming IPOs for Prestige Biopharma and HH&L…
On 25 November 2020, the European Commission adopted a Pharmaceutical Strategy for Europe with the stated aim of…
The latest from Chinese pharma, including domestic regulatory approval for Sinopharm’s COVID-19 vaccine, how…
A Tale of Two Americas The US stands as the biopharma innovation champion of the world, a global leader on nearly…
While great strides in gender diversity has been made within healthcare boardrooms and leadership teams globally,…
On 7 October 2020, the 2020 Nobel Prize in Chemistry was jointly awarded to Emmanuelle Charpentier and Jennifer A.…
Japanese pharma companies are already far lower-profile than their occidental counterparts but an even lesser-known…
The latest from Chinese pharma, including a drop in share prices for Chinese vaccine firms in the wake of…
On 15 November 2020, the world’s largest trade deal in terms of GDP – the Regional Comprehensive Economic…
Rare disease – defined in the US as a disease with a maximum patient population of 200,000 – is perhaps the…
With a series of reorganization initiatives, new leaders at the helm and exciting acquisitions, Novartis Oncology…